FDA
approval
· 2025-12-22
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved Amneal's supplemental application for a generic Buprenorphine HCl and Naloxone HCl product for the treatment of opioid use disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)